FERRIPROX is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Deferiprone.
Product ID | 10122-103_287670b2-60ba-4095-9fe3-7fab114bfc64 |
NDC | 10122-103 |
Product Type | Human Prescription Drug |
Proprietary Name | FERRIPROX |
Generic Name | Deferiprone |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2019-08-01 |
Marketing Category | NDA / |
Application Number | NDA021825 |
Labeler Name | Chiesi USA, Inc. |
Substance Name | DEFERIPRONE |
Active Ingredient Strength | 1000 mg/1 |
Pharm Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-08-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
10122-100 | FERRIPROX | deferiprone |
10122-101 | FERRIPROX | deferiprone |
10122-103 | FERRIPROX | DEFERIPRONE |
10122-104 | FERRIPROX | deferiprone |
52609-0006 | FERRIPROX | deferiprone |
52609-0007 | FERRIPROX | deferiprone |
52609-4502 | FERRIPROX | deferiprone |
0054-0576 | Deferiprone | Deferiprone |
0054-0711 | Deferiprone | Deferiprone |
51672-4196 | Deferiprone | Deferiprone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FERRIPROX 75719191 2550510 Live/Registered |
APOTEX INC. 1999-05-28 |